Filing Details
- Accession Number:
- 0000950170-24-015944
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-15 16:33:43
- Reporting Period:
- 2024-01-01
- Accepted Time:
- 2024-02-15 16:33:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661998 | Homology Medicines Inc. | FIXX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586226 | Arthur Tzianabos | C/O Homology Medicines, Inc. One Patriots Park Bedford MA 01730 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-01 | 14,280 | $0.00 | 122,675 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-01-01 | 19,140 | $0.00 | 141,815 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-09 | 13,037 | $0.57 | 128,778 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-01-01 | 14,280 | $0.00 | 14,280 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-01-01 | 19,140 | $0.00 | 19,140 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 19,720 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.
- The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5710 to $0.5712. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
- The RSUs are fully vested and do not have an expiration date.
- The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.
Billionaire Hedge Funds
